EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

●

12/5/2024

Form

424(b)(2)

(Form Type)

CVS Health Corporation

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security
Type

Security
Class
Title

Fee
Calculation
or Carry
Forward
Rule

Amount
Registered

Proposed
Maximum
Offering
Price Per
Unit

Maximum
Aggregate
Offering
Price

Fee
Rate

Amount of
Registration
Fee

Carry
Forward
Form
Type

Carry
Forward
File
Number

Carry
Forward
Initial
Effective
Date

Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward

Newly Registered Securities

Fees to be

Paid

Debt

7.000%

Fixed-to-Fixed

Rate Series A
Junior

Subordinated
Notes due
2055

457(r)

$2,250,000,000

100%

$2,250,000,000

0.0001531

$344,475

Fees to be

Paid

Debt

6.750%

Fixed-to-Fixed

Rate Series B
Junior
Subordinated
Notes due
2054

457(r)

$750,000,000

100%

$750,000,000

0.0001531

$114,825

Fees Previously Paid

Carry Forward Securities

Total Offering Amounts:

$3,000,000,000

$459,300

Total Fees Previously Paid:

$0.00

Total Fee Offsets:

$0.00

Net Fee Due:

$459,300

In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, CVS Health Corporation (the “Company”) initially deferred payment of all of the registration fees for the Registration Statement on Form

S-3

(Registration

No. 333-272200),

filed with the Securities and Exchange Commission (the “SEC”) on May 25, 2023. This filing fee exhibit is in connection with a final prospectus supplement (the “prospectus supplement”) dated December 3, 2024, filed by the Company with the SEC pursuant to Rule 424(b) of the Securities Act for the related offering.